Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;60(3):361-366.
doi: 10.20471/acc.2021.60.03.04.

SYNTHETIC CANNABINOID BONZAI RELATED CREATINE KINASE ENZYME ELEVATION: A TURKISH CENTER STUDY

Betul Erismis  1 , Deniz Yilmaz  1 , Ozlem Polat  1 , Hatice Deniz  1 , Mehmet Haluk Yucel  1 , Mehmet Hursitoglu  1
Affiliations

SYNTHETIC CANNABINOID BONZAI RELATED CREATINE KINASE ENZYME ELEVATION: A TURKISH CENTER STUDY

Betul Erismis et al. Acta Clin Croat. 2022 Feb.

Abstract

Synthetic cannabinoid (locally named 'Bonzai' in Turkey) use is increasing worldwide (especially among people with low income). One of its harmful adverse effects is an increase in serum levels of muscle enzymes (i.e., creatine kinase [CK]). The aim of this study was to determine the prevalence of Bonzai use in patients admitted with elevated CK levels and to compare the 1-month survival status of Bonzai users with that of non-Bonzai users. This retrospective study was conducted on a total of 468 patients, median (min-max) age 48±22 (18-93) years. It was found that 10.68% (n=50) of the patients presenting with elevated CK levels were using Bonzai (group 1), while the remaining 418 (89.32%) patients were non-Bonzai users (group 2). Median age was higher in group 2 as compared with group 1 (p=0.001). In group 1, the predominance of male (M) over female (F) patients was interestingly high, yielding a F:M ratio of 1/49 (χ2=110.03, p<0.001). The prevalence of Bonzai use among patients admitted to our center with elevated CK levels was 10.68%. The Bonzai group patients were younger and mostly males, and none of them died at 1 month of admission. These findings may help in the management of such clinical conditions and could be a pathfinder for further studies in this field.

Keywords: Addictive substances; Bonzai; Creatine kinase; Synthetic cannabinoids.

PubMed Disclaimer

References

    1. Hardy S, Thomas S, Stein S, Kelley R. Spice overdose and side effects. Retrieved January 21, 2020, from American Addiction Centers website: https://americanaddictioncenters.org/synthetic-cannabinoids/overdose
    1. Ergül DF, Ekemen S, Yelken BB. Synthetic cannabinoid ‘bonzai’ intoxication: Six case series. Turk Anesteziyoloji ve Reanimasyon Dernegi Dergisi. 2015;43(5):347–51. 10.5152/TJAR.2015.05668 - DOI - PMC - PubMed
    1. Yazici AB, Yazici E, Erol A. Delirium and high creatine kinase and myoglobin levels related to synthetic cannabinoid withdrawal. Case Rep Med. 2017;2017:3894749. 10.1155/2017/3894749 - DOI - PMC - PubMed
    1. Courts J, Maskill V, Gray A, Glue P. Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review. Australas Psychiatry. 2016;24(6):598–601. 10.1177/1039856216663733 - DOI - PubMed
    1. Degirmenci Y, Kececi H, Olmez N. A case of ischemic stroke after bonzai: synthetic cannabinoid from Turkey. Neurol Sci. 2016;37(2):299–300. 10.1007/s10072-015-2397-5 - DOI - PubMed

LinkOut - more resources